Does screening for Down's syndrome cause anxiety in pregnant women? A systematic review

Acta Obstetricia et Gynecologica Scandinavica

Volumn 94, Issue 1, 2015, Pages 15-27

  Lou, Stina ^a,b   Mikkelsen, Line ^a   Hvidman, Lone ^c   Petersen, Olav B ^c   Nielsen, Camilla Palmhøj ^a,b  

^a CFK Public Health and Quality Improvement Central Denmark Region ^*  (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

antenatal care and diagnosis; anxiety; down's syndrome; Pregnancy; screening

Indexed keywords

ANXIETY; DEPRESSION; DOWN SYNDROME; FEMALE; HIGH RISK PREGNANCY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT DECISION MAKING; PREGNANCY; PREGNANT WOMAN; PRENATAL CARE; PRENATAL SCREENING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STATE TRAIT ANXIETY INVENTORY; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; ATTITUDE TO HEALTH; COHORT ANALYSIS; COMPARATIVE STUDY; ETIOLOGY; EVIDENCE BASED MEDICINE; GENETIC SCREENING; GESTATIONAL AGE; MATERNAL WELFARE; PATHOPHYSIOLOGY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PROCEDURES; PSYCHOLOGY; RISK ASSESSMENT;

ANXIETY; ATTITUDE TO HEALTH; COHORT STUDIES; DOWN SYNDROME; EVIDENCE-BASED MEDICINE; FEMALE; GENETIC TESTING; GESTATIONAL AGE; HUMANS; MATERNAL WELFARE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 84919346385     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12482     Document Type: Review

References (49)

1. Danish National Board of Health. Guidelines for Fetal Diagnostics-Prenatal Information, Risk Assessment, Counseling and Diagnostics. Copenhagen: Danish National Board of Health, 2004.
2. Nicolaides KH, Chervenak FA, McCullough LB, Avgidou K, Papageorghiou A,. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol. 2005; 193: 322-6.
3. The Danish Counsil of Ethics. The Future of Prenatal Diagnosis. Copenhagen: The Danish Council of Ethics, 2009.
4. Landsman G,. Reconstructing Motherhood and Disability in an Age of "Perfect" Babies. London: Routledge, 2009.
5. Kvist M,. Frasortering af syge foster er arvehygiejne [Abortion of sick foetuses is eugenic ] (newspaper article). Kristeligt Dagblad 6 November 2009. Available online at: http://www.kristendom.dk/synspunkt/frasortering-af-syge-fostre-er-arvehygiejne (accessed 12 December, 2013).
6. Filly RA,. Obstetric sonography: the best way to terrify a pregnant woman. J Ultrasound Med. 2000; 19: 1-5.
7. Williams C, Sandall J, Lewando-Hundt G, Heyman B, Spencer K, Grellier R,. Women as moral pioneers? Experiences of first trimester antenatal screening. Soc Sci Med. 2005; 61: 1983-92.
8. Ohman SG, Saltvedt S, Waldenstrom U, Grunewald C, Olin-Lauritzen S,. Pregnant women's responses to information about an increased risk of carrying a baby with Down syndrome. Birth. 2006; 33: 64-73.
9. Heyman B, Hundt G, Sandall J, Spencer K, Williams C, Grellier R, et al. On being at higher risk: a qualitative study of prenatal screening for chromosomal abnormalities. Soc Sci Med. 2006; 62: 2360-72.
10. Weinans MJN, Huijssoon AMG, Tymstra T, Gerrits MCF, Beekhuis JR, Mantingh A,. How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy. Prenat Diagn. 2000; 20: 705-8.
11. Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS,. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess. 2004; 8: iii, ix-x, 1-109.
12. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Med. 2009; 6: e1000097.
13. Danish National Board of Health. Available online at: https://sundhedsstyrelsen.dk/da/sundhed/kvalitet-og-retningslinjer/medicinsk-teknologivurdering-mtv/litteraturvurdering (accessed March 15, 2014).
14. University of Oxford. Oxford Centre for Evidence-based Medicine: Levels of Evidence. 2009. Available online at: www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/ (accessed 2 September, 2014).
15. Kleinveld J, Timmermans D, de Smit D, Ader H, van der Wal G, ten Kate L,. Does prenatal screening influence anxiety levels of pregnant women? A longitudinal randomised controlled trial. Prenat Diagn. 2006; 26: 354-61.
16. Muller MA, Bleker OP, Bonsel GJ, Bilardo CM,. Nuchal translucency screening and anxiety levels in pregnancy and puerperium. Ultrasound Obstet Gynecol. 2006; 27: 357-61.
17. Öhman SG, Saltvedt S, Grunewald C, Waldenstrom U,. Does fetal screening affect women's worries about the health of their baby? A randomized controlled trial of ultrasound screening for Down's syndrome versus routine ultrasound screening. Acta Obstet Gynecol Scand. 2004; 83: 634-40.
18. Öhman SG, Saltvedt S, Grunewald C, Waldenstrom U,. Perception of risk in relation to ultrasound screening for Down's syndrome during pregnancy. Midwifery. 2009; 25: 264-76.
19. Chueh HY, Cheng PJ, Shaw SW, Lin CT, Hsu JJ, Hsieh TT,. Maternal anxiety about first trimester nuchal translucency screening and impact of positive screening results. Acta Obstet Gynecol Scand. 2007; 86: 1437-41.
20. Cheng PJ, Wu TL, Shaw SW, Chueh HY, Lin CT, Hsu JJ, et al. Anxiety levels in women undergoing prenatal maternal serum screening for Down syndrome: the effect of a fast reporting system by mobile phone short-message service. Prenat Diagn. 2008; 28: 417-21.
21. Lai FM, Ng CC, Yeo GS,. Does maternal serum screening for Down syndrome induce anxiety in younger mothers? Singapore Med J. 2004; 45: 375-8.
22. Barnes LBL, Harp D, Jung WS,. Reliability generalization of scores on the Speilberger State-Trait Anxiety Inventory. Educ Psychol Meas. 2002; 62: 603-18.
23. Spielberger B, Gorsuch RL, Lushene RE,. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto: Consulting Psychologist's Press, 1970.
24. Bekker HL, Legare F, Stacey D, O'Connor A, Lemyre L,. Is anxiety a suitable measure of decision aid effectiveness: a systematic review. Patient Educ Couns. 2003; 50: 255-62.
25. Öhman SG, Grunewald C, Waldenstrom U,. Women's worries during pregnancy: testing the Cambridge Worry scale on 200 Swedish women. Scand J Caring Sci. 2003; 17: 148-52.
26. Murray D, Cox J,. Screening for depression during pregnancy with the Edinburgh Postnatal Depression Scale. J Reprod Infant Psychol. 1990; 9: 99-107.
27. Ormond KE, Pergament E, Fine BA,. Pre-screening education in multiple marker screening programs: the effect on patient anxiety and knowledge. J Genet Couns. 1996; 5: 69-80.
28. Quagliarini D, Betti S, Brambati B, Nicolini U,. Coping with serum screening for Down syndrome when the result is given as a numeric value. Prenat Diagn. 1998; 18: 816-21.
29. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hermert AM,. A validation study of the Hospital Anxiety and Depression scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997; 27: 363-70.
30. Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, et al. The psychological effects of false positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diag. 1992; 12: 205-14.
31. Michie S, Smith D, Marteau TM,. Prenatal tests: how are women deciding? Prenat Diag. 1999; 19: 743-8.
32. Michie S, Smith D, McClennan A, Marteau TM,. Patient decision making: an evaluation of two different methods of presenting information about a screening test. Br J Health Psychol. 1997; 2: 317-26.
33. Abuelo DN, Hopmann MR, Barsel-Bowers G, Goldstein A,. Anxiety in women with low maternal serum alpha-fetoprotein screening results. Prenat Diagn. 1991; 11: 381-5.
34. Keenan KL, Basso D, Goldkrand J, Butler WJ,. Low level of maternal alpha-fetoprotein: Its associated anxiety and the effect of genetic counseling. Am J Obstet Gynecol. 1991; 164: 54-6.
35. Jorgensen FS,. User acceptability of an alpha-fetoprotein screening programme. Dan Med Bull. 1995; 42: 100-5.
36. Stefansdottir V, Skirton H, Jonasson K, Hardardottir H, Jonsson JJ,. Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies. Acta Obstet Gynecol Scand. 2010; 89: 931-8.
37. Dahl K, Hvidman L, Jorgensen FS, Henriques C, Olesen F, Kjaergaard H, et al. First-trimester Down syndrome screening: pregnant women's knowledge. Ultrasound Obstet Gynecol. 2011; 38: 145-51.
38. Dahl K, Hvidman L, Jorgensen FS, Kesmodel US,. Knowledge of prenatal screening and psychological management of test decisions. Ultrasound Obstet Gynecol. 2011; 38: 152-7.
39. Bekker HL, Hewison J, Thornton JG,. Applying decision analysis to facilitate informed decision making about prenatal diagnosis for Down syndrome: a randomised controlled trial. Prenat Diagn. 2004; 24: 265-75.
40. Stratham H, Green J,. Serum screening for Down's syndrome: some women's experiences. BMJ. 1993; 307: 174-6.
41. Santalahti P, Lattika AM, Ryynanen M, Hemmiki E,. Women's experiences of prenatal serum screening. Birth. 1996; 23: 101-7.
42. Aune I, Moller A,. "I want a choice, but I don't want to decide"-a qualitative study of pregnant women's experiences regarding early ultrasound risk assessment for chromosomal anomalies. Midwifery. 2012; 28: 14-23.
43. Ekelin M, Crang-Svalenius E, Dykes AK,. A qualitative study of mothers' and fathers' experiences of routine ultrasound examination in Sweden. Midwifery. 2004; 20: 335-44.
44. Da Silva EC, Silva SV, Damiao R, Fonseca EB, Garcia S, Lippi UG,. Stress and anxiety in pregnant women exposed to ultrasound. J Matern Fetal Neonatal Med. 2012; 25: 295-8.
45. Boukydis CF, Treadwell MC, Delaney-Black V, Boyes K, King M, Robinson T, et al. Women's responses to ultrasound examinations during routine screens in an obstetric clinic. J Ultrasound Med. 2006; 25: 721-8.
46. Ohman SG, Waldenstrom U,. Effect of first-trimester ultrasound screening for Down syndrome on maternal-fetal attachment-a randomized controlled trial. Sex Reprod Health. 2010; 1: 85-90.
47. Markens S, Browner CH, Preloran HM,. Interrogating the dynamics between power, knowledge and pregnant bodies. Sociol Health Illness. 2010; 32: 37-56.
48. Rapp R,. Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America. New York: Routledge, 1999.
49. Grant K-A, McMahon C, Austin M-P,. Maternal anxiety during transition to parenthood: A prospective study. J Affect Disorders. 2008; 108: 101-11.